<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174913</url>
  </required_header>
  <id_info>
    <org_study_id>099/2557</org_study_id>
    <nct_id>NCT02174913</nct_id>
  </id_info>
  <brief_title>Awakening in Spine Surgery: A Comparison Between Clinical Signs and Bispectral Index</brief_title>
  <official_title>Awakening in Spine Surgery Patients Having Neurophysiologic Monitoring: A Comparison Study Between Clinical Signs and Bispectral Index (BIS) Guided Target Controlled Infusion(TCI) of Propofol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BIS is one of several equipments used to monitor depth of anesthesia.Some studies found BIS
      can reduce total propofol dose when being used with target controlled infusion (TCI).The
      objective is to compare awakening time after spine surgery between using clinical signs and
      bispectral index (BIS) guided target controlled infusion(TCI) of propofol in patients having
      neurophysiologic monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      34 patients undergoing spine surgery will be enrolled and randomly assigned into two groups.
      We exclude patients who age under 18 and over 80 years, preoperative hemodynamics
      instability, propofol allergy, receiving drugs interfered with EEG, liver disease, Body Mass
      Index (BMI) over 30 kg/m2. Before induction the patient will be given 0.9% Sodium Chloride
      (NaCl) or acetate Ringer solution 7 ml/kg. Standard monitorings are used to all patients.

      Control group will receive fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and
      propofol TCI target 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to
      facilitate endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L.
      The TCI propofol will be adjusted by clinical monitoring. If the patient has minor movement,
      the propofol TCI will be increased incrementally to 0.5 mcg/ml higher level but if major
      movement occurs the dose will be increased to1.0 mcg/ml higher. When hypotension occurs, this
      will be treated by fluid loading 200 ml in 10 min if it is not improved, then ephedrine or
      norepinephrine will be given and the TCI dose will be decreased by 0.5 mcg/ml lower level but
      not lower than 3.0 mcg/ml. Hypertension will be treated by fentanyl bolus 0.5 mcg/kg and
      increasing TCI dose to 0.5 mcg/ml higher level but not more than 7 mcg/ml. If hypertension
      persist, the nicardipine or diltiazem will be given.

      Intervention group receives fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and
      propofol by TCI 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to facilitate
      endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L. Propofol will
      be adjusted by BIS monitoring. If the movement occurs and BIS 40-60, fentanyl 0.5 mcg/kg will
      be given, BIS &gt; 60, TCI dose will be increased 0.5 mcg/ml higher level until BIS 40-60. When
      hypotension occurs, if BIS 40-60, will be treated by load fluid 200 ml in 10 mins, then
      ephedrine or norepinephrine will be given, If BIS &lt; 40 the TCI dose will decrease 0.5 mcg/ml
      but not lower than 3.0 mcg/ml. Hypertension occurs, if BIS &gt; 60 will be treated by fentanyl
      bolus 0.5 mcg/kg and TCI dose will be increased 0.5 mcg/ml higher level but not more than 7
      mcg/ml if not improved, nicardipine or diltiazem will be given. if BIS 40-60, nicardipine or
      diltiazem will be given.

      This outcome measures are extubation time,total propofol dose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extubation Time</measure>
    <time_frame>4 hr</time_frame>
    <description>Awakening time from finished operation to endotracheal extubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Propofol Dosage</measure>
    <time_frame>From start anesthesia to finish operation</time_frame>
    <description>total propofol dosage = propofol dose from start to end of the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Spine Diseases</condition>
  <arm_group>
    <arm_group_label>bispectral index/TCI propofol/fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation. Fentanyl is used for analgesia and atracurium is used for tracheal intubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clinical signs/TCI propofol/fentanyl</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol. Fentanyl is used for analgesia and atracurium is used for tracheal intubation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bispectral index</intervention_name>
    <description>Bispectral index (BIS) is one of several technologies used to monitor depth of anesthesia.</description>
    <arm_group_label>bispectral index/TCI propofol/fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Target controlled infusion of propofol</intervention_name>
    <description>TCI propofol (3-7 mcg/dL, Schnider model) is used for total intravenous anesthesia in both groups</description>
    <arm_group_label>bispectral index/TCI propofol/fentanyl</arm_group_label>
    <arm_group_label>clinical signs/TCI propofol/fentanyl</arm_group_label>
    <other_name>TCI propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 1-2 mcg/kg iv for induction and then 0.5-1.0 mcg/kg/hr infusion is used for analgesic.</description>
    <arm_group_label>bispectral index/TCI propofol/fentanyl</arm_group_label>
    <arm_group_label>clinical signs/TCI propofol/fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atracurium</intervention_name>
    <description>Atracurium 0.6 mg/kg is used for endotracheal intubation</description>
    <arm_group_label>bispectral index/TCI propofol/fentanyl</arm_group_label>
    <arm_group_label>clinical signs/TCI propofol/fentanyl</arm_group_label>
    <other_name>Tracrium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spine surgery with neurophysiology monitoring

          -  ASA 1-3

          -  elective case

          -  cooperate patients

          -  Not receive drugs interfere with EEG

        Exclusion Criteria:

          -  unstable hemodynamics

          -  liver disease

          -  propofol allergy

          -  BMI &gt; 30

          -  complete cord lesion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manee Raksakietisak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahidol University, siriraj hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 12, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <results_first_submitted>September 19, 2016</results_first_submitted>
  <results_first_submitted_qc>June 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 13, 2020</results_first_posted>
  <last_update_submitted>June 28, 2020</last_update_submitted>
  <last_update_submitted_qc>June 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Awakening time</keyword>
  <keyword>Bispectral index</keyword>
  <keyword>clinical signs</keyword>
  <keyword>neurophysiologic monitoring</keyword>
  <keyword>spine surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Atracurium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bispectral Index</title>
          <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
        </group>
        <group group_id="P2">
          <title>Clinical Signs</title>
          <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>40 patients met the inclusion criteria; however, three patients in each group were discontinued from the study due to protocol violation.</population>
      <group_list>
        <group group_id="B1">
          <title>Bispectral Index</title>
          <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
        </group>
        <group group_id="B2">
          <title>Clinical Signs</title>
          <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.1" spread="11.6"/>
                    <measurement group_id="B2" value="48.0" spread="12.1"/>
                    <measurement group_id="B3" value="49.05" spread="11.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.8" spread="11.8"/>
                    <measurement group_id="B2" value="60.4" spread="8.1"/>
                    <measurement group_id="B3" value="61.6" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Extubation Time</title>
        <description>Awakening time from finished operation to endotracheal extubation.</description>
        <time_frame>4 hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bispectral Index</title>
            <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
          </group>
          <group group_id="O2">
            <title>Clinical Signs</title>
            <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
          </group>
        </group_list>
        <measure>
          <title>Extubation Time</title>
          <description>Awakening time from finished operation to endotracheal extubation.</description>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.3" spread="9.7"/>
                    <measurement group_id="O2" value="16.6" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Propofol Dosage</title>
        <description>total propofol dosage = propofol dose from start to end of the operation</description>
        <time_frame>From start anesthesia to finish operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bispectral Index</title>
            <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
          </group>
          <group group_id="O2">
            <title>Clinical Signs</title>
            <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Propofol Dosage</title>
          <description>total propofol dosage = propofol dose from start to end of the operation</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2,146" spread="742"/>
                    <measurement group_id="O2" value="2,340" spread="839"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From start anesthesia to 24 hr after operation.</time_frame>
      <desc>The cardiovascular, respiratory, neurological or other complications during the intraoperative period are recorded.</desc>
      <group_list>
        <group group_id="E1">
          <title>Bispectral Index</title>
          <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
        </group>
        <group group_id="E2">
          <title>Clinical Signs</title>
          <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Department of Anesthesiology, Siriraj Hospital</name_or_title>
      <organization>Mahidol University</organization>
      <phone>66-2-41979889 ext 501</phone>
      <email>manee95@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

